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ABSTRACT 
Has conducted research on the use of steroids triamsinolon asetonid as pseudo-othematoma 
medical therapy. The purpose of this study was to determine the effectiveness triamsinolon 
asetonid. Prevention of the formation of serum in the lesion, so that pseudo-othematoma 
can be cured without surgery. Surgery and preventing of the formation collagen tissue in 
the lesion, so that the pseudo-othematoma can be cured without deformity. It is expected 
the establishment  of a pseudo-othematoma practical for health personnel, effective, 
efficient, safe and comfortable for the patient. This study design is the design of a 
randomized controled pretest-postest design. In the test group were treated with 
triamsinolon asetonid intracutaneus injected in lesion area with the number according to 
the percentage of the amount of teraphy effusion before. Then press verban installed. In the 
control group, only pressing verban installed. From the research results obtained, whish 
after the third treatment using the triamsinolon asetonid, pseudo-othematoma disease 
looked  very meaningful. Due to its unique histological structure of the ear, then the 
manipulation of the ear is moe advisable to be careful, to prevent new lession with various 
impacts.  
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INTRODUCTION 
Pseduo-othematoma are heaps of serous fluid between the perichondrium and ear 
cartilage. Also by the name of seroma(1). The literature of the first initial report with the 
name calling Pseudocyst(2). Source literature  until recently still used, both in literature and 
science magazines, because the material is relatively more extensive discustion. 
The main cause is the trauma in which the helix is a prominent part of the head to 
the side so that the most likely to experience trauma(3,4). 
Judging from the way pseudo-othematoma illness is part of othematoma. The 
difference lies in the severity of pathological abnormalities that occur. When a trauma is 
not string enough to cause rupture of blood vessels only networks reaction will occur, 
resulting in the accumulation of serum perichondrium. Another factor that is the locus of 
resistance to minoris certain areas on the ear linked with the embryological development of 
the ear region  from the first meeting of the arch and the second brankialis. This resistance 
locus minoris are predisposing factors for the occurrence of degeneration in the next 
period, especially in a state kacheksia(2). Other predisposing factors are histological 
structure of the ear skin of lateral side firmly attached to the connective tissue that make up 
perichondrium. Perichondrium while not attached tightly to the cartilage underneath, so 
when the trauma and / or in the conditions mentiod above, cartilage perichondrium and 
prone beneath each other disposition(5). 
Trauma mentioned above will lead to increased permeability of blood vessels. 
Trauma will cause tissue damage and the damaged tissue will be issued a mediator, one of 
which is histamine which can affect the endothelial tight junctions. Therefore, serum 
would be out of the blood vessels and accumulated in the gap between the cartilage and ear 
perichondrium. Tumor necrosis factor TNF – α is released from damaged tissue, will 
stimulate the formation of collagen(6). 
To have attempted to overcome a variety of ways but the liquid form 
again, and this situation does not often leave deformities of auricle thickening(7, 8, 9, 10). 
Triamsinolon asetonid  like other steroid preparations through the glucocorticoid 
receptor complex formation in the cytoplasm, which then penetrate into the cell nucleus 
and the role of inflammation mediators inhibit the formation of local cell lesions(11). Thus 
triamsinolon asetonid work for(12, 13, 14). (1) improve the permeability of capillaries that 
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sustained serum in the lumen; (2) maintain the integrity of the plasma membrane and the 
cell membrane, so that the destruction of the cell and organelle swelling of the cytoplasm 
can be restored and prevented; (3) lisosome stabilization by maintaining membrane 
integrity; (4) to prevent fibroblast proliferation, thus preventing the formation of scar 
tissue. 
 
MATERIAL AND METHODS 
Research design 
This study used a randomized design controlled pretest-postest design, to determine the 
effectiveness of disease triamsinolon asetonid pseudo-othematoma with protocol design 
(design protocol) as follows: 
 
                                                                                        O1                           O3 
                                                                          R                    Treatment 
   pseudo  
othematoma                               sampel 
                                                     
                                                                         R                      Control 
                                                                                       O2                            O4 
                                                                                 
Note: 
R   : Allocation random permuted blocking with random sampling 
O1 : the treatment group pre-treatment. 
O2 : pre-treatment control group. 
O3 : Effect on treatment group. 
O4 : Effects on the control group. 
 
Control group     : The group that received therapy aspirations and      
                             dressing press. 
Treatment group : The group that received aspirations therapy and triamsinolon asetonid.  
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Place and time research 
Research carried out in Section / ENT- Head and Neck Surgery Department / 
Health Sciences Faculty of Medicine ( UNUD ) / Sanglah Hospital Denpasar. The study 
began early in January 2009 until the fulfillment of a theoretical sample of late September 
2009, and performed on every working day. 
 
Giving way medicine 
 Group test: Pinna disinfected with alcohol 70%. After aspiration of the effusion by 
researchers with the syringe using a needle size 23 G x 1 1/4, the test group injected 
triamsinolone asetonide prepared in 1cc syringe. 
Triamsinolone injected intra-cutaneous doses as follows(15). 
 
a. ≤ 0.5 cc effusion required 1 / 3 of it. 
b. Effusion> 0.5 to 1.0 cc is required 1 / 4 of it. 
c. Effusion> 1.0 to 1.5 cc is required 1 / 5 of it. 
d. Effusion> 1.5 to 2.0 cc is required 1 / 6 of it. 
e. Effusion> 2.0 to 2.5 cc is required 1 / 7 of it. 
f. Effusion> 2.5 to 3.0 cc is required 1 / 8 of it.  
g. Effusion> 3.0 to 3.5 cc is required 1 / 9 of it. 
h. Effusion> 3.5 cc required 1 / 10 or less it. 
 
Treatment do it for three times, the 1st day, 3rd day, and 5th day, and evaluation conducted 
on the 3rd, 5th, and 7th day. For patients who recovered, the evaluation was also performed 
on 2 weeks. If the of the 3rd evaluation, the day of the 7th, patients had not healed, 
treatment declared unsuccessful. In contrast to patients who have recovered to-3rd 
treatment, no longer receive treatment and the patient remained present for the evaluation 
according to the schedule previously set. For patients testing revealed no recovery after the 
study, sought other treatments, such as gypsum fixation. 
 Control group: Pinna disinfected with alcohol 70%. Aspirations performed by 
researchers with a needle syringe disposible size 23G x 1 1/4.  For the control group fitted 
with a bandage deper press fixation. Treatment do it for three times the 1st day, the 3rd day, 
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5th day, and evaluation conducted on the 3rd, 5th, and 7th day. For patients who recovered, 
the evaluation was also performed in 2 weeks. If the evaluation of the 3rd day, and the day 
of 7th, patients had not healed, treatment declared unsuccessful. In contrast to patients who 
have recovered before the 3rd day treatment, no longer receive treatment and only 
replacement of dressing so that the patient remains present for the evaluation according to 
a predetermined schedule. For patients who declared did’nt cured after the study, sought 
other treatments, such as aspiration and gypsum fixation. 
 
RESULTS 
 This research was conducted from early January 2009 until the end of September 
2009 carried out a study of 15 subjects with pseudo-othematoma. Of 15 patients, 7 patients 
evaluated in the test group and 8 patients in the control group. 
 
Subject characteristics: 
 All patients in this study were male. The youngest age was 26 years old and the 
oldest 65 years (Table I). 
 
Table I 
List of Pseudo-Patient othematoma 
No. Name Age Sex DC R/L Size TSL RV KM 
1. NS 38 M 07 R 10 X 9 T + - 
2. HD 38 M 05 R 6 X 5 T + - 
3. MG 58 M 11 L 12 X 11 T + - 
4 MK 36 M 07 L 11 X 10 T + - 
5. AI 25 M 09 R 16 X 15 T + - 
6. MN 40 M 11 R 8 X 6 T + - 
7. PA 30 M 24 R 9 X 8 T + - 
8. KW 36 M 07 R 17 X 16 T + - 
9. GS 26 M 06 R 15 X 14 T + - 
10. SK 33 M 16 L 18 X 16 T + - 
11. IM 51 M 06 R 14 X 12 T + - 
12. BH 65 M 14 R 11 X 9 T + - 
13. NW 31 M 22 R 15 X 12 T + - 
14. NP 45 M 06 R 17 X 15 T + - 
15. MS 43 M 06 R 12 X 11 T + - 
Description: DC: The duration of Complaints In Day Counts 
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  R : Right 
  L  : Left 
 TSL: transilluminates 
 RV : Rivalta 
 GM : Germs 
 M    : Men 
 W    : Women 
 Q    : Light 
 G    : Dark 
 M    : Male 
 Age: Age In Years 
 Size: Size In Mm 
 
Results Clinical use as therapy Triamsinolon Asetonid Medika-mentosa Pseudo-
othematoma 
 
Table II 
Clinical results Triamsinolon Asetonid use as therapy 
Medical Pseudo-othematoma 
 
 Trial Control result 
Recover 7 1 8 (53,33%) 
Not cured 0 7 7 (46,67%) 
Result 7 8 15 (100%) 
 
As a result of the end use of triamsinolon asetonid pseudo-othematoma can be seen in 
Table II. Of those tested statistically using Chi Square test with Yates’ correction. 
 α  = 0.01 
 d f = 1 
 X2 table = 6.63 
X2count 7.41 > 6.63, then HO is rejected. Use Results Triamsinolon means Asetonid as 
Pseudo-othematoma Medical therapy has a benefits or meaningful. 
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DISCUSSION 
 The pupose of this study as mentioned before is to determine efficacy in the 
treatment triamsinolon asetonid pseudo-othematoma, is an attempt to get a way practical 
medical treatment of pseudo-othematoma for health personnel and the effective, efficient, 
safe and comfortable for the patient. 
 All patients in this study were male. This study reported on 15 patients with the 
youngest aged 26 years and the oldest 65 years. 
Engel found the youngest aged 25 years and the oldest 44 years(2). Hartmann is quoted 
Engel(2) reported 12 cases, all found in the young adult age, with good health status. 
Meanwhile, at the age of 50 years and over according to Engel cited Meyer(2), tend to be 
formed a hematoma. 
 In this study 15 patients obtained from all men. This is in accordance with the 
literature. But there is no literature pertaining to the background of these sex differences. 
Mentioned only one of the causes of pseudo-othematoma is a result of the minoris locus, 
because embryological development is not running as it should. Besides the histological 
where the structure of the lateral lobe skin clung with perichondrium, while perichondrium 
loosely attached to the cartilage(3, 5). 
 The results of the clinical use of steroids triamsinolon asetonid as pseudo-
othematoma medical therapy have adequate properties. Thus the purpose of disease control 
was achieved pseudo-othematoma practical, effective, efficient, safe and comfortable. 
 
CONCLUSION 
 From this research can be concluded that the use of steroids is Triamsinolon 
Asetonid as pseudo- othematoma medical therapy proved very effective. 
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